Jeil Pharma Holdings Inc (KRX:002620)
South Korea · Delayed Price · Currency is KRW 8,210.00
+50.00 (0.61%)
Dec 19, 2025, 3:30 PM KST
Jeil Pharma Holdings Market Cap
Jeil Pharma Holdings has a market cap or net worth of 126.03 billion as of December 19, 2025. Its market cap has decreased by -2.84% in one year.
Market Cap
126.03B
Enterprise Value
365.86B
Revenue
707.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,210.00
Market Cap Chart
Since August 30, 1995, Jeil Pharma Holdings's market cap has increased from 26.30B to 126.03B, an increase of 379.29%. That is a compound annual growth rate of 5.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 126.03B | 4.99% |
| Dec 30, 2024 | 120.05B | -33.56% |
| Dec 28, 2023 | 180.68B | -23.57% |
| Dec 29, 2022 | 236.41B | -3.75% |
| Dec 30, 2021 | 245.62B | -24.53% |
| Dec 30, 2020 | 325.44B | 24.71% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.86T |
| Celltrion | 40.61T |
| ALTEOGEN | 22.65T |
| ABL Bio | 10.50T |
| SK Biopharmaceuticals | 10.35T |
| Yuhan | 8.59T |
| LigaChem Biosciences | 6.27T |
| Peptron | 6.18T |